2-[(3Z,8E)-1-butylundeca-3,8-dien-1-yl]phenol(51546-63-5)
- Name: 2-[(3Z,8E)-1-butylundeca-3,8-dien-1-yl]phenol
- Synonyms:
- Molecular Formula:C21H32O
- Molecular Weight:300.484
- CAS Registry Number:51546-63-5
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.51546-63-5 3-[(8Z,11Z)-pentadeca-8,11-dienyl]phenol
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.51546-63-5 3-[(8Z,11Z)-pentadeca-8,11-dienyl]phenol
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.51546-63-5 2-[(3Z,8E)-1-butylundeca-3,8-dien-1-yl]phenol
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:2-[(3Z,8E)-1-butylundeca-3,8-dien-1-yl]phenol
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)] CAS No.51546-63-5 Cardanol diene
Assay:鈮?5% Appearance:Neat Oil Application:For research use only.
Min. Order:0
Supplier:BOC Sciences [
United States]
Other Product
- 556-82-1/3-Methyl-2-buten-1-ol
- 98171-39-2/Fatty acids, C16-18, 2-(1-carboxyethoxy)-1-methyl-2-oxoethyl esters
- 199165-87-2/Chryseno[1,2-c]furan-1(3H)-one,4,5,5a,5b,6,7,- 7a,8,9,10,11,11a,11b,12,13,13a-hexadecahydro- 9,13-dihydroxy-5b,8,8,11a,13a-pentamethyl-,(5aS,5bR,7aR,9S,11aR,11bR,13R,13aS)-
- 90640-61-2/Amines, hydrogenated tallow alkyl, reaction products with kaolinitic clays
- 81424-61-5/Ajmaline phenylbarbiturate
- 101560-01-4/methyl (11beta,13xi)-15-{[(2E)-3,4-dimethylpent-2-enoyl]oxy}-2-(beta-D-glucopyranosyloxy)-11,12-dihydroxy-1,16-dioxo-13,20-epoxypicras-2-en-21-oate
- 1402-88-6/Ascosin
- 138430-53-2/2-amino-2-deoxyglucopyranosyl-(1-4)-2-acetamido-2-deoxyglucopyranosyl-(1-4)-2-acetamido-2-deoxyglucopyranoside
- 645-83-0/3-(METHYLSULFONYL)PROPANOIC ACID
- 82586-04-7/ethyl [5-amino-3-(biphenyl-4-yl)-1,2-dihydropyrido[3,4-b]pyrazin-7-yl]carbamate
- 81053-29-4/(2S,7R)-7-[(1R,3E)-1-Chloro-5-hexyn-3-enyl]-2-[(R)-1-bromopropyl]-1-oxacyclohepta-4-ene
- 14186-06-2/1-[2-(9,10-dihydro-9,10-ethanoanthracen-11-ylmethoxy)ethyl]piperidine hydrochloride (1:1)
- 1336-78-3/Amphodyn
- 58744-74-4/2-(4-iodophenyl)-3-thioxohexahydro-1H-[1,2,4]triazolo[1,2-a]pyridazin-1-one
- 129658-13-5/Benzeneethanamine, 2,5-dimethoxy-N-methyl-4-(pentylthio)-, (Z)-2-buten edioate (1:1)
- 68516-63-2/hydrogen [4-[4-(diethylamino)-3',4'-bis(sulphonatomethyl)benzhydrylidene]cyclohexa-2,5-dien-1-ylidene]diethylammonium, monosodium salt
- 68026-83-5/10-({(2Z)-2-[1-(4-nitrophenyl)ethylidene]hydrazino}acetyl)-10H-phenothiazine
- 151703-06-9/5-methoxydehydropodophyllotoxin
- 51546-63-5/2-[(3Z,8E)-1-butylundeca-3,8-dien-1-yl]phenol
- 132741-72-1/Kaur-16-ene-12,15-dione,3-(acetyloxy)-1,7,- 14-trihydroxy-,(1R,3â,7R,14R)-
- 56527-66-3/4-{[2-(5-nitrothiophen-2-yl)-1,3-thiazol-4-yl]carbonyl}morpholine
- 67706-97-2/4-[(9-ethylcarbazol-3-yl)-[4-(methyl-phenyl-amino)phenyl]methyl]-N-methyl-N-phenyl-aniline
- 63059-65-4/2-[3-[3-[1,5-dihydro-3-methyl-5-oxo-1-(4-sulphophenyl)-4H-pyrazol-4-ylidene]-5,5-dimethylcyclohex-1-en-1-yl]prop-2-enylidene]-2H-benzoxazole-3-propylsulphonic acid
- 141430-36-6/Piperidine,4-[2-(3,4-dichlorophenoxy)ethyl]-1-pentyl-
- 71892-94-9/Pamamycin
- 42902-46-5/[3-(4-methoxyphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl carbamate
- 59953-61-6/N-[1-(4-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl)propan-2-yl]benzamide
- 6036-25-5/narbomycin
- 93763-45-2/Leach solutions, bauxite
- 78406-76-5/N-(2-ethoxyphenyl)-N~2~-ethyl-3-[ethyl(methyl)amino]-N~2~-methylalaninamide